Agenus Liabilities And Stockholders Equity from 2010 to 2024

AGEN Stock  USD 2.72  0.24  8.11%   
Agenus Liabilities And Stockholders Equity yearly trend continues to be very stable with very little volatility. Liabilities And Stockholders Equity is likely to grow to about 329.6 M this year. Liabilities And Stockholders Equity is the total of all liabilities and equity in the company, which should equal Agenus' total assets according to the accounting equation. View All Fundamentals
 
Liabilities And Stockholders Equity  
First Reported
2000-03-31
Previous Quarter
292.4 M
Current Value
238.5 M
Quarterly Volatility
110.4 M
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Agenus financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Agenus' main balance sheet or income statement drivers, such as Depreciation And Amortization of 14.3 M, Interest Expense of 102.8 M or Selling General Administrative of 82.7 M, as well as many indicators such as Price To Sales Ratio of 1.8, Dividend Yield of 0.0018 or Days Sales Outstanding of 72.0. Agenus financial statements analysis is a perfect complement when working with Agenus Valuation or Volatility modules.
  
Check out the analysis of Agenus Correlation against competitors.

Latest Agenus' Liabilities And Stockholders Equity Growth Pattern

Below is the plot of the Liabilities And Stockholders Equity of Agenus Inc over the last few years. It is the total of all liabilities and equity in the company, which should equal the company's total assets according to the accounting equation. Agenus' Liabilities And Stockholders Equity historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Agenus' overall financial position and show how it may be relating to other accounts over time.
Liabilities And Stockholders Equity10 Years Trend
Slightly volatile
   Liabilities And Stockholders Equity   
       Timeline  

Agenus Liabilities And Stockholders Equity Regression Statistics

Arithmetic Mean185,782,934
Geometric Mean129,375,865
Coefficient Of Variation76.17
Mean Deviation115,344,006
Median155,335,000
Standard Deviation141,502,646
Sample Variance20023T
Range446.2M
R-Value0.85
Mean Square Error6009.3T
R-Squared0.72
Significance0.000062
Slope26,872,819
Total Sum of Squares280322T

Agenus Liabilities And Stockholders Equity History

2024329.6 M
2023313.9 M
2022413.6 M
2021466 M
2020214.5 M
2019155.3 M
2018136.4 M

About Agenus Financial Statements

Agenus investors utilize fundamental indicators, such as Liabilities And Stockholders Equity, to predict how Agenus Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Liabilities And Stockholders Equity313.9 M329.6 M

Pair Trading with Agenus

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Agenus position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Agenus will appreciate offsetting losses from the drop in the long position's value.

Moving together with Agenus Stock

  0.82VALN Valneva SE ADRPairCorr
  0.76ERNA Eterna TherapeuticsPairCorr

Moving against Agenus Stock

  0.89BMY Bristol Myers SquibbPairCorr
  0.74GILD Gilead SciencesPairCorr
  0.64ESPR Esperion TherapeuticsPairCorr
  0.55DYAI Dyadic InternationalPairCorr
The ability to find closely correlated positions to Agenus could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Agenus when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Agenus - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Agenus Inc to buy it.
The correlation of Agenus is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Agenus moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Agenus Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Agenus can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Agenus Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Agenus' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Agenus Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Agenus Inc Stock:
Check out the analysis of Agenus Correlation against competitors.
You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Agenus. If investors know Agenus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Agenus listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(11.02)
Revenue Per Share
7.808
Quarterly Revenue Growth
0.033
Return On Assets
(0.22)
Return On Equity
(12.79)
The market value of Agenus Inc is measured differently than its book value, which is the value of Agenus that is recorded on the company's balance sheet. Investors also form their own opinion of Agenus' value that differs from its market value or its book value, called intrinsic value, which is Agenus' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Agenus' market value can be influenced by many factors that don't directly affect Agenus' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Agenus' value and its price as these two are different measures arrived at by different means. Investors typically determine if Agenus is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Agenus' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.